Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
immune globulin (human) (Gamastan) (1 trial)
varicella zoster immune globulin (human) (varizig) (1 trial)
Immunologic Deficiency Syndromes (Phase 3)
Syndrome (Phase 3)
Trials (2 total)
Trial APIs (2 total)